Dhingra Kapil
SEC CIK 1456849 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Dir | 0 | — | $33.0K | 2 | 2025-12-09 | 2025-12-09 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-11 | 2025-12-09 | REPL | Replimune Group, Inc. | Dhingra Kapil | Dir | S - Sale+OE | $10.40 | -3,169 | 0 | -100% | -$33.0K |
| D | 2025-12-11 | 2025-12-09 | REPL | Replimune Group, Inc. | Dhingra Kapil | Dir | M - OptEx | $1.75 | +3,169 | 3,169 | New | +$5,546 |
Purchase Sale Sale after option exercise All abbreviations